Search

Showing "11155" results for ""

Heart disease `polypill` to be tested in HIV patients

UK HIV patients have high levels of primary drug resistance

Hepatitis C combination therapies in pill form move nearer

New US HIV infections fall between 2001 and 2004, but complex picture emerges

HIV treatment activism moves into the TB field

Over 40 million now living with HIV worldwide

Study of nucleoside-sparing regimens stopped early due to high failure rates; NRTIs likely to remain therapeutic backbone for the time being

Patients switching from other PIs to unboosted atazanavir maintain viral suppression

TMC125 is safe and effective in patients with NNRTI resistance

People with HIV and CD4 cell counts over 500 cells/mm3 have same death rate as general population, French study reveals

Infection with harmless hepatitis G doesn't mean that HIV treatment works better

One in three HIV infections remain undiagnosed in the UK

Zinc supplement reduces diarrhoea in children with HIV

Ability to control HIV without drugs rare and transient, but linked to better outcomes, study shows

OK study continues to show potency of Kaletra monotherapy after 72 weeks

Why are results from randomised controlled trials better than in the real world?

Low uptake of T-20 may be caused by doctors misjudging patient attitudes to self-injection

Bone problems caused by HIV and duration of anti-HIV treatment

Receive the latest HIV research and conference news

Showing "11155" results for ""

Heart disease `polypill` to be tested in HIV patients

UK HIV patients have high levels of primary drug resistance

Hepatitis C combination therapies in pill form move nearer

New US HIV infections fall between 2001 and 2004, but complex picture emerges

HIV treatment activism moves into the TB field

Over 40 million now living with HIV worldwide

Study of nucleoside-sparing regimens stopped early due to high failure rates; NRTIs likely to remain therapeutic backbone for the time being

Patients switching from other PIs to unboosted atazanavir maintain viral suppression

TMC125 is safe and effective in patients with NNRTI resistance

People with HIV and CD4 cell counts over 500 cells/mm3 have same death rate as general population, French study reveals

Infection with harmless hepatitis G doesn't mean that HIV treatment works better

One in three HIV infections remain undiagnosed in the UK

Zinc supplement reduces diarrhoea in children with HIV

Ability to control HIV without drugs rare and transient, but linked to better outcomes, study shows

OK study continues to show potency of Kaletra monotherapy after 72 weeks

Why are results from randomised controlled trials better than in the real world?

Low uptake of T-20 may be caused by doctors misjudging patient attitudes to self-injection

Bone problems caused by HIV and duration of anti-HIV treatment

Receive the latest HIV research and conference news